Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
81.34
Dollar change
+0.63
Percentage change
0.78
%
IndexRUT P/E46.63 EPS (ttm)1.74 Insider Own2.49% Shs Outstand57.86M Perf Week-1.30%
Market Cap4.73B Forward P/E22.35 EPS next Y3.64 Insider Trans-5.12% Shs Float56.66M Perf Month-0.67%
Income101.95M PEG4.33 EPS next Q0.88 Inst Own102.19% Short Float4.43% Perf Quarter11.27%
Sales1.28B P/S3.69 EPS this Y10.71% Inst Trans1.98% Short Ratio7.42 Perf Half Y13.67%
Book/sh21.35 P/B3.81 EPS next Y9.20% ROA5.08% Short Interest2.51M Perf Year-2.33%
Cash/sh10.05 P/C8.09 EPS next 5Y10.77% ROE8.45% 52W Range62.58 - 85.18 Perf YTD7.08%
Dividend Est.- P/FCF35.37 EPS past 5Y15.74% ROI4.85% 52W High-4.51% Beta0.87
Dividend TTM- Quick Ratio4.38 Sales past 5Y7.42% Gross Margin42.94% 52W Low29.98% ATR (14)1.44
Dividend Ex-Date- Current Ratio6.03 EPS Y/Y TTM18.90% Oper. Margin10.88% RSI (14)50.70 Volatility1.95% 1.56%
Employees6950 Debt/Eq0.70 Sales Y/Y TTM9.62% Profit Margin7.96% Recom1.64 Target Price92.24
Option/ShortYes / Yes LT Debt/Eq0.69 EPS Q/Q35.53% Payout0.00% Rel Volume1.05 Prev Close80.71
Sales Surprise2.52% EPS Surprise7.78% Sales Q/Q9.07% EarningsApr 30 AMC Avg Volume338.54K Price81.34
SMA20-0.91% SMA503.59% SMA2009.89% Trades Volume356,880 Change0.78%
Date Action Analyst Rating Change Price Target Change
Apr-11-24Initiated CL King Buy $88
Feb-07-24Initiated BofA Securities Neutral $87
Dec-21-23Upgrade Canaccord Genuity Hold → Buy $100
Dec-20-22Downgrade Canaccord Genuity Buy → Hold $73 → $72
Jan-05-21Upgrade Needham Hold → Buy $65
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Jun-18-24 10:57AM
09:25AM
Jun-17-24 06:00AM
Jun-11-24 09:50AM
Jun-07-24 09:45AM
11:31AM Loading…
May-30-24 11:31AM
May-23-24 09:50AM
May-22-24 12:23PM
12:21PM
May-21-24 09:25AM
May-16-24 04:05PM
May-15-24 04:52PM
04:05PM
12:11PM
May-14-24 11:58AM
09:25AM Loading…
09:25AM
May-01-24 12:47PM
11:27AM
10:47AM
09:15AM
03:32AM
Apr-30-24 09:55PM
06:30PM
05:38PM
05:30PM
04:38PM
04:05PM
Apr-23-24 10:01AM
Apr-10-24 09:33AM
Mar-29-24 11:30AM
09:40AM Loading…
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
Mar-18-24 05:19PM
Mar-08-24 05:00PM
09:40AM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
Feb-28-24 07:00PM
06:15PM
05:21PM
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
10:51AM
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Peterson NeilCHIEF OPERATING OFFICERJun 10 '24Option Exercise44.807,500336,00022,319Jun 12 01:28 PM
Peterson NeilCHIEF OPERATING OFFICERJun 10 '24Sale81.857,500613,84514,819Jun 12 01:28 PM
Parra Raul Jr.CFO AND TREASURERMar 12 '24Sale73.956,480479,18212,007Mar 13 06:36 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Option Exercise28.2025,000705,00067,223Mar 08 03:40 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Sale75.6825,0001,891,92542,223Mar 08 03:40 PM
Peterson NeilCHIEF OPERATING OFFICERMar 06 '24Option Exercise44.807,500336,00014,819Mar 08 10:11 AM
Gunderson Thomas JamesDirectorMar 04 '24Option Exercise34.4025,000860,00037,414Mar 05 12:13 PM
Gunderson Thomas JamesDirectorMar 04 '24Sale76.0318,1571,380,51319,257Mar 05 12:13 PM
Evans Stephen C.DirectorMar 04 '24Sale76.351,00076,3487,226Mar 05 10:13 AM
Millner F. AnnDirectorJan 22 '24Option Exercise34.4020,000688,00049,960Jan 24 10:49 AM
Millner F. AnnDirectorJan 22 '24Sale80.0020,0001,600,00029,960Jan 24 10:49 AM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.20200,0005,640,0001,167,916Aug 29 06:08 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.206,000169,20012,888Aug 29 06:08 PM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Option Exercise28.208,000225,6008,000Aug 23 11:32 AM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Sale67.918,000543,2880Aug 23 11:32 AM
ANDERSON A SCOTTDirectorAug 09 '23Option Exercise50.5025,0001,262,50071,397Aug 11 05:30 PM
ANDERSON A SCOTTDirectorAug 09 '23Sale69.4022,1801,539,29249,217Aug 11 05:30 PM